Table 2B.

Clinical laboratory data for patients with COVID-19.

Variable	COVID-19 positive
	Mild or no symptoms2 N = 38	Severe acute symptoms3 N = 33	MIS-C4 N = 31	p-Value	Multiple comp*
Blood pressure, median (IQR)
Systolic blood pressure, mmHg	104 (98–117) N = 33	111 (103–116) N = 33	102 (100–111) N = 28	0.548	All equal
Diastolic blood pressure, mmHg	64 (60–75) N = 33	67 (59–72) N = 33	64 (61–71) N = 28	0.859	All equal
Clinical labs, median (IQR)
AST, (IU/L)	25 (20–41) N = 20	38 (26–60) N = 21	31 (25–37) N = 29	0.081	All equal
ALT, (IU/L)	26 (21–35) N = 21	36 (28–58) N = 21	30 (24–41) N = 29	0.063	All equal
BUN, mmol/L	3.6 (2.9–5.0) N = 29	3.6 (2.5–5.4) N = 30	3.6 (2.5–16) N = 31	0.949	All equal
Creatinine, μmol/L	32.7 (23.0–59.2) N = 29	38.9 (26.5–57.5) N = 30	40.7 (29.2–49.5) N = 31	0.858	All equal
C reactive protein, mg/L	1.5 (0.8–3.2) N = 10	17.7 (7.3–49.4) N = 10	27.8 (4.1–92.8) N = 28	0.003	2 < 3 & 4
Hemoglobin, g/L	122 (114–133) N = 29	117 (99–126) N = 26	100 (91–113) N = 30	<0.001	2, & 3 > 4
Hematocrit, %	37.0 (34.2–39.4) N = 29	35.4 (32.1–38.8) N = 26	30.2 (28.0–33.5) N = 29	<0.001	2, & 3 > 4
RDW, fL	13.4 (12.5–14.2) N = 29	14.6 (13.3–17.7) N = 26	14.2 (13.5–15.6) N = 29	0.009	2 < 3
WBC, cells/ml	8.0 (6.0–11.7)	8.7 (6.2–10.7)	6.6 (5.0–9.3)	0.406	All equal
Platelets, cells/ml	338 (249–433)	278 (181–362)	436 (254–605)	0.080	All equal

ALT, alanine transaminase; AST, aspartate transaminase; BUN, blood urea nitrogen; IU/L, international units per liter; IQR, interquartile range; mmHg, millimeters of mercury; mg/dl, milligrams per deciliter; MIS-C, multisystem inflammatory syndrome of children; RDW, red cell distribution width; WBC, white blood cell count.

^*Multiple comparisons. Bonferroni adjusted for three comparisons, significant p-value < 0.0167.